Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,334 | 71 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $318.64 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $214.13 | 13 | $0 (2024) |
| PFIZER INC. | $197.35 | 9 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $169.11 | 4 | $0 (2019) |
| Lilly USA, LLC | $84.59 | 6 | $0 (2020) |
| ABBVIE INC. | $68.27 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $32.07 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $32.07 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.02 | 2 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $24.65 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $165.51 | 8 | Novo Nordisk Inc ($69.02) |
| 2022 | $23.52 | 1 | Phadia US Inc. ($23.52) |
| 2020 | $161.63 | 6 | PFIZER INC. ($87.25) |
| 2019 | $285.14 | 17 | AstraZeneca Pharmaceuticals LP ($86.76) |
| 2018 | $368.31 | 19 | Novo Nordisk Inc ($143.53) |
| 2017 | $329.42 | 20 | E.R. Squibb & Sons, L.L.C. ($78.56) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Oncology | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Obesity | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Gastroenterology | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Obesity | ||||||
| 06/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Obesity | ||||||
| 04/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2022 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $23.52 | General |
| Category: Allergy/Immunology | ||||||
| 10/15/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/03/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Diabetes | ||||||
| 02/25/2020 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: IMMUNOLOGY | ||||||
| 02/20/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $87.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/11/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/07/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiovascular | ||||||
| 12/04/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/19/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Respiratory | ||||||
| 11/05/2019 | Novo Nordisk Inc | Ozempic (Drug), Tresiba | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Diabetes | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: DIABETES | ||||||
| 10/22/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.95 | General |
| Category: Cardiovascular | ||||||
| 10/08/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Central Nervous System (CNS) | ||||||
| 09/10/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Respiratory | ||||||
| 08/20/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 760 | 1,208 | $290,336 | $73,627 |
| 2022 | 7 | 625 | 1,072 | $156,564 | $69,030 |
| 2021 | 7 | 609 | 1,064 | $156,681 | $70,686 |
| 2020 | 8 | 806 | 1,121 | $144,933 | $54,257 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 286 | 618 | $192,816 | $45,724 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 204 | 306 | $67,626 | $17,269 | 25.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 58 | 58 | $6,670 | $4,172 | 62.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $5,712 | $2,166 | 37.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 59 | 59 | $5,959 | $1,703 | 28.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 27 | $3,699 | $1,026 | 27.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 77 | 88 | $2,112 | $709.39 | 33.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,822 | $611.89 | 16.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 24 | $1,920 | $245.41 | 12.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 300 | 635 | $111,760 | $48,223 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 192 | 300 | $34,200 | $15,880 | 46.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 35 | 35 | $2,135 | $2,092 | 98.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $4,176 | $1,136 | 27.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 34 | $1,020 | $923.78 | 90.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 23 | $1,656 | $593.19 | 35.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 19 | 21 | $1,617 | $181.40 | 11.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 299 | 620 | $109,120 | $48,869 | 44.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 203 | 334 | $38,076 | $18,097 | 47.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 38 | 40 | $2,880 | $1,370 | 47.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $3,480 | $1,117 | 32.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 13 | 13 | $793.00 | $792.96 | 100.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 25 | 26 | $2,002 | $267.36 | 13.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $330.00 | $173.14 | 52.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 273 | 436 | $76,736 | $27,197 | 35.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 240 | 376 | $42,864 | $15,396 | 35.9% |
About Dr. Willis Roberts, M.D
Dr. Willis Roberts, M.D is a Internal Medicine healthcare provider based in Milledgeville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689604449.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Willis Roberts, M.D has received a total of $1,334 in payments from pharmaceutical and medical device companies, with $165.51 received in 2024. These payments were reported across 71 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,334).
As a Medicare-enrolled provider, Roberts has provided services to 2,800 Medicare beneficiaries, totaling 4,465 services with total Medicare billing of $267,600. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Milledgeville, GA
- Active Since 07/04/2006
- Last Updated 07/23/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689604449
Products in Payments
- ELIQUIS (Drug) $267.61
- Tresiba (Drug) $111.21
- SYMBICORT (Drug) $96.06
- CHANTIX (Drug) $84.82
- Wegovy (Drug) $69.02
- Victoza (Drug) $61.46
- FARXIGA (Drug) $48.47
- Synthroid (Drug) $41.63
- Ozempic (Drug) $41.60
- AIRSUPRA (Drug) $41.11
- TRADJENTA (Drug) $40.58
- INVOKANA (Drug) $32.07
- TRULICITY (Drug) $26.08
- XIFAXAN (Drug) $24.65
- ImmunoCAP (Device) $23.52
- JANUVIA (Drug) $22.94
- EVENITY (Biological) $20.15
- SOLIQUA 100/33 (Drug) $20.04
- Levemir (Drug) $19.89
- Cologuard Collection Kit (Device) $16.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Milledgeville
Dr. Saqib Nazir, M.d, M.D
Internal Medicine — Payments: $13,728
Turkessa Walker, Md, MD
Internal Medicine — Payments: $6,766
Dr. Patrice Boddie, M.d, M.D
Internal Medicine — Payments: $1,895
Dragos Filimon, M.d, M.D
Internal Medicine — Payments: $1,533
Dr. Catherine Roberts, M.d, M.D
Internal Medicine — Payments: $1,454
Dr. Charles Shiver, M.d, M.D
Internal Medicine — Payments: $1,327